Biotie Therapies ^Companies

Biotie Therapies is a specialized drug development company that focuses on central nervous system and inflammatory diseases. They have a range of innovative small molecule and biological drug candidates in various stages of clinical development. Their products target diseases with high unmet medical needs, such as addiction, rheumatoid arthritis, and chronic obstructive pulmonary disease. Their most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development with their licensing partner, H. Lundbeck A/S.